-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Pseudomonas aeruginosa Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Pseudomonas aeruginosa Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Edetate Disodium + Ethyl...
-
Product Insights
Alcohol Addiction – Drugs In Development, 2023
Global Markets Direct’s, ‘Alcohol Addiction - Drugs In Development, 2023’, provides an overview of the Alcohol Addiction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alcohol Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Alcoholic Hepatitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Alcoholic Hepatitis - Drugs In Development, 2023’, provides an overview of the Alcoholic Hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alcoholic Hepatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Non Alcoholic Fatty Liver Disease (NAFLD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) - Drugs In Development, 2023’, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Sector Analysis
Americas Alcoholic Beverages Sport Sponsorship Landscape – Biggest Brands and Spenders, Venue Rights, Deals, Trends and Case Studies
Americas Alcoholic Beverages Sports Sponsorship Landscape Overview Professional sports teams are the main recipients of the alcoholic beverage sector’s sponsorship deals. Alcoholic beverages are responsible for a few of the biggest sponsorship deals across the Americas with many highly recognized federations, events, and teams, including a few of the most profitable sports leagues in the world. The Americas alcoholic beverages sports sponsorship landscape report provides deep insights into the Americas alcoholic beverages sector sponsorship market trend, most active sport, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Larsucosterol Sodium in Alcoholic Hepatitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Larsucosterol Sodium in Alcoholic Hepatitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Larsucosterol Sodium in Alcoholic Hepatitis Drug Details: DUR-928 (DV-928) is under...
-
Sector Analysis
EMEA Alcoholic Beverages Sport Sponsorship Landscape – Biggest Brands and Spenders, Venue Rights, Deals, Trends and Case Studies
EMEA Alcoholic Beverages Sport Sponsorship Report Overview The EMEA alcoholic beverages sector has recorded an estimated annual spend of $ 403.66 million in sports sponsorship for 2023. There are 338 different brands currently engaged in sports sponsorship agreements across EMEA. There has been an increase in deal value owing to the mutually beneficial partnerships between alcoholic beverage brands and sports rights holders. These sports partnerships offer immense opportunities for the alcoholic beverages brands to raise the profile of the brand...
-
Sector Analysis
Non-Alcoholic Beverages Packaging Industry Trends, Opportunities, Growth Analysis and Forecast to 2027
Non-Alcoholic Beverages Packaging Industry Report Overview The non-alcoholic beverages packaging market size was 1,080.9 billion units in 2022 and is anticipated to grow at a CAGR of more than 3% during 2022-2027. The non-alcoholic beverages packaging market report brings together multiple data sources to provide a comprehensive overview of the non-alcoholic beverages packaging industry. Non-Alcoholic Beverages Packaging Industry Outlook 2022-2027 (Billion Units) Buy the Full Report for More Insights on Non-Alcoholic Beverages Packaging Market Forecasts Download a Free Sample Report...
-
Sector Analysis
Asia-Pacific Alcoholic Beverages Sport Sponsorship Landscape – Biggest Brands and Spenders, Venue Rights, Deals, Trends and Case Studies
Asia-Pacific Alcoholic Beverages Sport Sponsorship Report Overview The APAC alcoholic beverages sector has recorded an estimated annual spend of $147.26 million in sports sponsorship in 2023. There are 236 different brands currently engaged in sport sponsorship agreements across APAC. The factors driving alcoholic beverages sports sponsorship are the co-creation of content, social activation, intensified efforts to encourage responsible drinking, and brand initiatives to meet the changing consumer demand in the APAC region. The APAC alcoholic beverages sports sponsorship landscape report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acloproxalap in Alcohol Poisoning
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acloproxalap in Alcohol Poisoning Drug Details: Acloproxalap (ADX-629) is under development for the treatment of...